Official Publications Regeneron Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-09 pm EDT			5-day change	1st Jan Change
767.85 ^USD	-0.99%		+0.79%	-0.52%

Apr. 08	Bernstein Adjusts Regeneron Pharmaceuticals Price Target to $921 From $925, Maintains Outperform Rating	MT
Apr. 08	Regeneron Expects $0.81 per Share Net Income Impact From $102 Million R&D Charges for Q1	MT

Feb. 03	SEC Filing 10K	CO
Jan. 29	SEC Filing 8K	CO
Jan. 29	Slide show results	CO
Jan. 29	Annual results	CO
25-10-27	3rd quarter results	CO
25-10-27	Slide show Q3	CO
25-10-27	SEC Filing 10Q-3	CO
25-10-27	SEC Filing 8K	CO
25-07-31	Slide show half-year results	CO
25-07-31	1st-half-year results	CO
25-07-31	SEC Filing 10Q-2	CO
25-07-31	SEC Filing 8K	CO
25-06-12	Shareholders meeting voting results	CO
25-04-28	Slide show Q1	CO
25-04-28	SEC Filing 10Q-1	CO
25-04-28	SEC Filing 8K	CO
25-04-28	1st quarter results	CO
25-02-04	SEC Filing 10K	CO
25-02-03	Annual results	CO
25-02-03	Slide show results	CO
24-10-30	3rd quarter results	CO
24-10-30	Slide show Q3	CO
24-10-30	SEC Filing 8K	CO
24-10-30	SEC Filing 10Q-3	CO
24-07-31	SEC Filing 10Q-2	CO